Caption Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,000
Closed -$718K 1651
2023
Q4
$718K Buy
+23,000
New +$826K 0.01% 876
2023
Q3
Sell
-23,000
Closed -$1.21M 1533
2023
Q2
$1.21M Buy
+23,000
New +$1.4M 0.02% 623
2022
Q4
Sell
-23,374
Closed -$1.47M 1686
2022
Q3
$1.65M Buy
+23,374
New +$2M 0.02% 702
2022
Q2
Sell
-21,766
Closed -$1.4M 1810
2022
Q1
$1.74M Buy
+21,766
New +$1.62M 0.02% 801
2021
Q2
Sell
-1
Closed 1550
2021
Q1
$0 Buy
+1
New +$100 ﹤0.01% 1376
2020
Q3
Sell
-207
Closed -$12K 1242
2020
Q2
$12K Sell
207
-7,254
-97% -$296K ﹤0.01% 886
2020
Q1
$240K Buy
+7,461
New +$251K 0.01% 673
2019
Q4
Sell
-1,500
Closed -$49.5K 998
2019
Q3
$39K Buy
+1,500
New +$45.6K ﹤0.01% 661
2018
Q4
Sell
-25,000
Closed -$1.2M 608
2018
Q3
$1.2M Buy
+25,000
New +$1.02M 0.07% 315

Other funds holding STAA

Caption Management's STAA Position: Q1 2024 in Review

Caption Management sold out of STAAR Surgical (STAA) in Q1 2024, closing a stake of 23,000 shares — an estimated $718K sold.

Caption Management first reported a position in STAA in Q3 2018 and held it in 9 quarters. The position peaked at $1.74M in Q1 2022. 198 funds tracked by Wall St. Rank hold STAA as of Q1 2024.

  • Caption Management reported no remaining STAAR Surgical position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 23,000 STAAR Surgical shares in Q1 2024, an estimated $718K.
  • Caption Management first reported a position in STAAR Surgical in Q3 2018 and held it in 9 quarters.
  • Caption Management's STAAR Surgical position peaked at $1.74M in Q1 2022.
  • 198 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.